TY - JOUR PY - 2018 J2 - Biochem. Biophys. Res. Commun. SN - 0006-291X T2 - Biochemical and Biophysical Research Communications VL - 503 IS - 3 DO - 10.1016/j.bbrc.2018.07.088 TI - Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways UR - https://www.cheric.org/research/tech/periodicals/view.php?seq=1662775 KW - Interleukin-22 (IL-22) KW - Triple negative breast cancer (TNBC) KW - Target therapy AU - Wang SQ AU - Yao YN AU - Yao MY AU - Fu PF AU - Wang WL SP - 1605 EP - 1609 LA - English ER -